Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

The integral function of the endocytic recycling compartment is regulated by RFFL-mediated ubiquitylation of Rab11 effectors.

Sakai R, Fukuda R, Unida S, Aki M, Ono Y, Endo A, Kusumi S, Koga D, Fukushima T, Komada M, Okiyoneda T.

J Cell Sci. 2019 Feb 7;132(3). pii: jcs228007. doi: 10.1242/jcs.228007.

PMID:
30659120
2.

Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer.

Fukuda R, Okiyoneda T.

Front Pharmacol. 2018 Sep 27;9:1100. doi: 10.3389/fphar.2018.01100. eCollection 2018. Review.

3.

Chaperone-Independent Peripheral Quality Control of CFTR by RFFL E3 Ligase.

Okiyoneda T, Veit G, Sakai R, Aki M, Fujihara T, Higashi M, Susuki-Miyata S, Miyata M, Fukuda N, Yoshida A, Xu H, Apaja PM, Lukacs GL.

Dev Cell. 2018 Mar 26;44(6):694-708.e7. doi: 10.1016/j.devcel.2018.02.001. Epub 2018 Mar 1.

4.

Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.

Bagdany M, Veit G, Fukuda R, Avramescu RG, Okiyoneda T, Baaklini I, Singh J, Sovak G, Xu H, Apaja PM, Sattin S, Beitel LK, Roldan A, Colombo G, Balch W, Young JC, Lukacs GL.

Nat Commun. 2017 Aug 30;8(1):398. doi: 10.1038/s41467-017-00444-4.

5.

[Peripheral quality control mechanism eliminating aberrant proteins from the plasma membrane].

Okiyoneda T.

Seikagaku. 2014 Feb;86(1):54-8. Japanese. No abstract available.

PMID:
24693698
6.

Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane.

Apaja PM, Foo B, Okiyoneda T, Valinsky WC, Barriere H, Atanasiu R, Ficker E, Lukacs GL, Shrier A.

Mol Biol Cell. 2013 Dec;24(24):3787-804. doi: 10.1091/mbc.E13-07-0417. Epub 2013 Oct 23.

7.

Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Okiyoneda T, Veit G, Dekkers JF, Bagdany M, Soya N, Xu H, Roldan A, Verkman AS, Kurth M, Simon A, Hegedus T, Beekman JM, Lukacs GL.

Nat Chem Biol. 2013 Jul;9(7):444-54. doi: 10.1038/nchembio.1253. Epub 2013 May 12.

8.

Fixing cystic fibrosis by correcting CFTR domain assembly.

Okiyoneda T, Lukacs GL.

J Cell Biol. 2012 Oct 15;199(2):199-204. doi: 10.1083/jcb.201208083.

9.

STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein.

Sato T, Sako Y, Sho M, Momohara M, Suico MA, Shuto T, Nishitoh H, Okiyoneda T, Kokame K, Kaneko M, Taura M, Miyata M, Chosa K, Koga T, Morino-Koga S, Wada I, Kai H.

Mol Cell. 2012 Jul 13;47(1):99-110. doi: 10.1016/j.molcel.2012.04.015. Epub 2012 May 17.

10.

Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.

Rabeh WM, Bossard F, Xu H, Okiyoneda T, Bagdany M, Mulvihill CM, Du K, di Bernardo S, Liu Y, Konermann L, Roldan A, Lukacs GL.

Cell. 2012 Jan 20;148(1-2):150-63. doi: 10.1016/j.cell.2011.11.024.

11.

Endocytic sorting of CFTR variants monitored by single-cell fluorescence ratiometric image analysis (FRIA) in living cells.

Barrière H, Apaja P, Okiyoneda T, Lukacs GL.

Methods Mol Biol. 2011;741:301-17. doi: 10.1007/978-1-61779-117-8_20.

12.

Protein quality control at the plasma membrane.

Okiyoneda T, Apaja PM, Lukacs GL.

Curr Opin Cell Biol. 2011 Aug;23(4):483-91. doi: 10.1016/j.ceb.2011.04.012. Epub 2011 May 14. Review.

13.

CFTR Folding Consortium: methods available for studies of CFTR folding and correction.

Peters KW, Okiyoneda T, Balch WE, Braakman I, Brodsky JL, Guggino WB, Penland CM, Pollard HB, Sorscher EJ, Skach WR, Thomas PJ, Lukacs GL, Frizzell RA.

Methods Mol Biol. 2011;742:335-53. doi: 10.1007/978-1-61779-120-8_20.

14.

Peripheral protein quality control removes unfolded CFTR from the plasma membrane.

Okiyoneda T, Barrière H, Bagdány M, Rabeh WM, Du K, Höhfeld J, Young JC, Lukacs GL.

Science. 2010 Aug 13;329(5993):805-10. doi: 10.1126/science.1191542. Epub 2010 Jul 1.

15.

Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

Hutt DM, Herman D, Rodrigues AP, Noel S, Pilewski JM, Matteson J, Hoch B, Kellner W, Kelly JW, Schmidt A, Thomas PJ, Matsumura Y, Skach WR, Gentzsch M, Riordan JR, Sorscher EJ, Okiyoneda T, Yates JR 3rd, Lukacs GL, Frizzell RA, Manning G, Gottesfeld JM, Balch WE.

Nat Chem Biol. 2010 Jan;6(1):25-33. doi: 10.1038/nchembio.275. Epub 2009 Dec 6.

16.

Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles.

Barriere H, Bagdany M, Bossard F, Okiyoneda T, Wojewodka G, Gruenert D, Radzioch D, Lukacs GL.

Mol Biol Cell. 2009 Jul;20(13):3125-41. doi: 10.1091/mbc.E09-01-0061. Epub 2009 May 6.

17.

N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic.

Glozman R, Okiyoneda T, Mulvihill CM, Rini JM, Barriere H, Lukacs GL.

J Cell Biol. 2009 Mar 23;184(6):847-62. doi: 10.1083/jcb.200808124.

18.

Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and DeltaF508 CFTR.

Okiyoneda T, Niibori A, Harada K, Kohno T, Michalak M, Duszyk M, Wada I, Ikawa M, Shuto T, Suico MA, Kai H.

Biochim Biophys Acta. 2008 Sep;1783(9):1585-94. doi: 10.1016/j.bbamcr.2008.04.002. Epub 2008 Apr 16.

19.

Phosphatidic acid metabolism regulates the intracellular trafficking and retrotranslocation of CFTR.

Hashimoto Y, Okiyoneda T, Harada K, Ueno K, Sugahara T, Yamashita A, Shuto T, Suico MA, Kai H.

Biochim Biophys Acta. 2008 Jan;1783(1):153-62. Epub 2007 Sep 7.

20.

Cell surface dynamics of CFTR: the ins and outs.

Okiyoneda T, Lukacs GL.

Biochim Biophys Acta. 2007 Apr;1773(4):476-9. Epub 2007 Jan 19. Review.

21.

Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin.

Harada K, Okiyoneda T, Hashimoto Y, Oyokawa K, Nakamura K, Suico MA, Shuto T, Kai H.

Biochem Biophys Res Commun. 2007 Feb 9;353(2):351-6. Epub 2006 Dec 13.

PMID:
17178109
22.

Bafilomycin A1-sensitive pathway is required for the maturation of cystic fibrosis transmembrane conductance regulator.

Okiyoneda T, Niibori A, Harada K, Kohno T, Hashimoto Y, Kusuhara H, Takada T, Shuto T, Suico MA, Sugiyama Y, Kai H.

Biochim Biophys Acta. 2006 Oct;1763(10):1017-23. Epub 2006 Aug 26.

23.

Calreticulin facilitates the cell surface expression of ABCG5/G8.

Okiyoneda T, Kono T, Niibori A, Harada K, Kusuhara H, Takada T, Shuto T, Suico MA, Sugiyama Y, Kai H.

Biochem Biophys Res Commun. 2006 Aug 18;347(1):67-75. Epub 2006 Jun 14.

PMID:
16806071
24.

Calreticulin negatively regulates the cell surface expression of cystic fibrosis transmembrane conductance regulator.

Harada K, Okiyoneda T, Hashimoto Y, Ueno K, Nakamura K, Yamahira K, Sugahara T, Shuto T, Wada I, Suico MA, Kai H.

J Biol Chem. 2006 May 5;281(18):12841-8. Epub 2006 Mar 9.

25.

Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells.

Shuto T, Furuta T, Oba M, Xu H, Li JD, Cheung J, Gruenert DC, Uehara A, Suico MA, Okiyoneda T, Kai H.

FASEB J. 2006 Apr;20(6):782-4. Epub 2006 Feb 14.

PMID:
16478769
26.

Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo.

Shimohara S, Murakami T, Morikawa M, Matsuo J, Nagayama S, Shuto T, Suico MA, Okiyoneda T, Yamatsu I, Mizushima T, Shimasaki T, Kai H.

Int J Oncol. 2005 Dec;27(6):1527-33.

PMID:
16273208
27.

Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.

Shuto T, Kato K, Mori Y, Viriyakosol S, Oba M, Furuta T, Okiyoneda T, Arima H, Suico MA, Kai H.

Biochem Biophys Res Commun. 2005 Dec 23;338(3):1402-9. Epub 2005 Oct 26.

PMID:
16263085
28.

Sp1-dependent regulation of Myeloid Elf-1 like factor in human epithelial cells.

Koga T, Suico MA, Nakamura H, Taura M, Lu Z, Shuto T, Okiyoneda T, Kai H.

FEBS Lett. 2005 May 23;579(13):2811-6. Epub 2005 Apr 21.

29.

Sp1 is involved in the transcriptional activation of lysozyme in epithelial cells.

Suico MA, Koga T, Shuto T, Hisatsune A, Lu Z, Basbaum C, Okiyoneda T, Kai H.

Biochem Biophys Res Commun. 2004 Nov 26;324(4):1302-8.

PMID:
15504356
30.

Characterization of the trafficking pathway of cystic fibrosis transmembrane conductance regulator in baby hamster kidney cells.

Okiyoneda T, Harada K, Yamahira K, Wada I, Hashimoto Y, Ueno K, Suico MA, Shuto T, Kai H.

J Pharmacol Sci. 2004 Aug;95(4):471-5. Epub 2004 Jul 31.

31.

[p97-mediated membrane fusion is required for Golgi and ER assembly].

Kondo H, Uchiyama K, Okiyoneda T.

Tanpakushitsu Kakusan Koso. 2004 May;49(7 Suppl):916-9. Review. Japanese. No abstract available.

PMID:
15168492
32.

Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression.

Okiyoneda T, Harada K, Takeya M, Yamahira K, Wada I, Shuto T, Suico MA, Hashimoto Y, Kai H.

Mol Biol Cell. 2004 Feb;15(2):563-74. Epub 2003 Oct 31.

33.

Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator.

Okiyoneda T, Wada I, Jono H, Shuto T, Yoshitake K, Nakano N, Nagayama S, Harada K, Isohama Y, Miyata T, Kai H.

FEBS Lett. 2002 Aug 28;526(1-3):87-92.

34.

[Introduction of the conventional method of DNA transfection by adenovirus vector].

Okiyoneda T, Kai H.

Nihon Yakurigaku Zasshi. 2002 Jun;119(6):337-44. Japanese.

PMID:
12089905
35.

Characterization of CFTR expression in a human pulmonary mucoepidermoid carcinoma cell line, NCI-H292 cells.

Nagayama S, Kai H, Okiyoneda T, Horikawa S, Miyata T.

FEBS Lett. 1999 Jul 23;455(3):215-8.

Supplemental Content

Loading ...
Support Center